2024-02-012025-01-312025-01-31false06479528KENNETH NG SURGERY LTD.2025-10-2886230falseiso4217:GBPxbrli:pure064795282024-01-31064795282025-01-31064795282024-02-012025-01-31064795282023-01-31064795282024-01-31064795282023-02-012024-01-3106479528bus:SmallEntities2024-02-012025-01-3106479528bus:AuditExempt-NoAccountantsReport2024-02-012025-01-3106479528bus:FullAccounts2024-02-012025-01-3106479528bus:PrivateLimitedCompanyLtd2024-02-012025-01-3106479528core:WithinOneYear2025-01-3106479528core:AfterOneYear2025-01-3106479528core:WithinOneYear2024-01-3106479528core:AfterOneYear2024-01-3106479528core:ShareCapital2025-01-3106479528core:SharePremium2025-01-3106479528core:RevaluationReserve2025-01-3106479528core:OtherReservesSubtotal2025-01-3106479528core:RetainedEarningsAccumulatedLosses2025-01-3106479528core:ShareCapital2024-01-3106479528core:SharePremium2024-01-3106479528core:RevaluationReserve2024-01-3106479528core:OtherReservesSubtotal2024-01-3106479528core:RetainedEarningsAccumulatedLosses2024-01-3106479528core:LandBuildings2025-01-3106479528core:PlantMachinery2025-01-3106479528core:Vehicles2025-01-3106479528core:FurnitureFittings2025-01-3106479528core:OfficeEquipment2025-01-3106479528core:NetGoodwill2025-01-3106479528core:IntangibleAssetsOtherThanGoodwill2025-01-3106479528core:ListedExchangeTraded2025-01-3106479528core:UnlistedNon-exchangeTraded2025-01-3106479528core:LandBuildings2024-01-3106479528core:PlantMachinery2024-01-3106479528core:Vehicles2024-01-3106479528core:FurnitureFittings2024-01-3106479528core:OfficeEquipment2024-01-3106479528core:NetGoodwill2024-01-3106479528core:IntangibleAssetsOtherThanGoodwill2024-01-3106479528core:ListedExchangeTraded2024-01-3106479528core:UnlistedNon-exchangeTraded2024-01-3106479528core:LandBuildings2024-02-012025-01-3106479528core:PlantMachinery2024-02-012025-01-3106479528core:Vehicles2024-02-012025-01-3106479528core:FurnitureFittings2024-02-012025-01-3106479528core:OfficeEquipment2024-02-012025-01-3106479528core:NetGoodwill2024-02-012025-01-3106479528core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3106479528core:ListedExchangeTraded2024-02-012025-01-3106479528core:UnlistedNon-exchangeTraded2024-02-012025-01-3106479528core:MoreThanFiveYears2024-02-012025-01-3106479528core:Non-currentFinancialInstruments2025-01-3106479528core:Non-currentFinancialInstruments2024-01-3106479528dpl:CostSales2024-02-012025-01-3106479528dpl:DistributionCosts2024-02-012025-01-3106479528core:LandBuildings2024-02-012025-01-3106479528core:PlantMachinery2024-02-012025-01-3106479528core:Vehicles2024-02-012025-01-3106479528core:FurnitureFittings2024-02-012025-01-3106479528core:OfficeEquipment2024-02-012025-01-3106479528dpl:AdministrativeExpenses2024-02-012025-01-3106479528core:NetGoodwill2024-02-012025-01-3106479528core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3106479528dpl:GroupUndertakings2024-02-012025-01-3106479528dpl:ParticipatingInterests2024-02-012025-01-3106479528dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-012025-01-3106479528core:ListedExchangeTraded2024-02-012025-01-3106479528dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-012025-01-3106479528core:UnlistedNon-exchangeTraded2024-02-012025-01-3106479528dpl:CostSales2023-02-012024-01-3106479528dpl:DistributionCosts2023-02-012024-01-3106479528core:LandBuildings2023-02-012024-01-3106479528core:PlantMachinery2023-02-012024-01-3106479528core:Vehicles2023-02-012024-01-3106479528core:FurnitureFittings2023-02-012024-01-3106479528core:OfficeEquipment2023-02-012024-01-3106479528dpl:AdministrativeExpenses2023-02-012024-01-3106479528core:NetGoodwill2023-02-012024-01-3106479528core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3106479528dpl:GroupUndertakings2023-02-012024-01-3106479528dpl:ParticipatingInterests2023-02-012024-01-3106479528dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012024-01-3106479528core:ListedExchangeTraded2023-02-012024-01-3106479528dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012024-01-3106479528core:UnlistedNon-exchangeTraded2023-02-012024-01-3106479528core:NetGoodwill2025-01-3106479528core:IntangibleAssetsOtherThanGoodwill2025-01-3106479528core:LandBuildings2025-01-3106479528core:PlantMachinery2025-01-3106479528core:Vehicles2025-01-3106479528core:FurnitureFittings2025-01-3106479528core:OfficeEquipment2025-01-3106479528core:AfterOneYear2025-01-3106479528core:WithinOneYear2025-01-3106479528core:ListedExchangeTraded2025-01-3106479528core:UnlistedNon-exchangeTraded2025-01-3106479528core:ShareCapital2025-01-3106479528core:SharePremium2025-01-3106479528core:RevaluationReserve2025-01-3106479528core:OtherReservesSubtotal2025-01-3106479528core:RetainedEarningsAccumulatedLosses2025-01-3106479528core:NetGoodwill2024-01-3106479528core:IntangibleAssetsOtherThanGoodwill2024-01-3106479528core:LandBuildings2024-01-3106479528core:PlantMachinery2024-01-3106479528core:Vehicles2024-01-3106479528core:FurnitureFittings2024-01-3106479528core:OfficeEquipment2024-01-3106479528core:AfterOneYear2024-01-3106479528core:WithinOneYear2024-01-3106479528core:ListedExchangeTraded2024-01-3106479528core:UnlistedNon-exchangeTraded2024-01-3106479528core:ShareCapital2024-01-3106479528core:SharePremium2024-01-3106479528core:RevaluationReserve2024-01-3106479528core:OtherReservesSubtotal2024-01-3106479528core:RetainedEarningsAccumulatedLosses2024-01-3106479528core:NetGoodwill2023-01-3106479528core:IntangibleAssetsOtherThanGoodwill2023-01-3106479528core:LandBuildings2023-01-3106479528core:PlantMachinery2023-01-3106479528core:Vehicles2023-01-3106479528core:FurnitureFittings2023-01-3106479528core:OfficeEquipment2023-01-3106479528core:AfterOneYear2023-01-3106479528core:WithinOneYear2023-01-3106479528core:ListedExchangeTraded2023-01-3106479528core:UnlistedNon-exchangeTraded2023-01-3106479528core:ShareCapital2023-01-3106479528core:SharePremium2023-01-3106479528core:RevaluationReserve2023-01-3106479528core:OtherReservesSubtotal2023-01-3106479528core:RetainedEarningsAccumulatedLosses2023-01-3106479528core:AfterOneYear2024-02-012025-01-3106479528core:WithinOneYear2024-02-012025-01-3106479528core:Non-currentFinancialInstrumentscore:CostValuation2024-02-012025-01-3106479528core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-012025-01-3106479528core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-012025-01-3106479528core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-012025-01-3106479528core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-012025-01-3106479528core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-012025-01-3106479528core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3106479528core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3106479528core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3106479528core:Non-currentFinancialInstrumentscore:CostValuation2025-01-3106479528core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-3106479528core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-3106479528core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-3106479528core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-3106479528core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-3106479528core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-3106479528core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-3106479528core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-3106479528core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3106479528core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3106479528core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3106479528core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3106479528core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3106479528core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3106479528core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3106479528core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3106479528core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3106479528bus:Director12024-02-012025-01-3106479528bus:Director22024-02-012025-01-3106479528core:FurnitureFittingsToolsEquipment2024-01-3106479528core:FurnitureFittingsToolsEquipment2024-02-012025-01-3106479528core:FurnitureFittingsToolsEquipment2025-01-31

KENNETH NG SURGERY LTD.

Registered Number
06479528
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2025

KENNETH NG SURGERY LTD.
Company Information
for the year from 1 February 2024 to 31 January 2025

Directors

PARKER, Mohamed Sayeed, Dr
SALIE-PARKER, Rushdiyah, Dr

Registered Address

2nd Floor Grove House
Lowlands Road
Harrow
HA1 3AW

Registered Number

06479528 (England and Wales)
KENNETH NG SURGERY LTD.
Balance Sheet as at
31 January 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3114,600144,727
114,600144,727
Current assets
Stocks42,5002,500
Debtors5411,588503,428
Cash at bank and on hand23,17434,399
437,262540,327
Creditors amounts falling due within one year6(152,403)(104,509)
Net current assets (liabilities)284,859435,818
Total assets less current liabilities399,459580,545
Creditors amounts falling due after one year7(53,494)(102,790)
Net assets345,965477,755
Capital and reserves
Called up share capital1,0001,000
Profit and loss account344,965476,755
Shareholders' funds345,965477,755
The financial statements were approved and authorised for issue by the Board of Directors on 28 October 2025, and are signed on its behalf by:
PARKER, Mohamed Sayeed, Dr
Director
Registered Company No. 06479528
KENNETH NG SURGERY LTD.
Notes to the Financial Statements
for the year ended 31 January 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Plant and machinery33-
Fixtures and fittings25-
Vehicles-4
Office Equipment25-
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Classification of financial liabilities Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Basic financial liabilities Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20252024
Average number of employees during the year117
3.Tangible fixed assets

Plant & machinery

Vehicles

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 February 24139,199107,639-5,883252,721
Additions--5,1265,01010,136
At 31 January 25139,199107,6395,12610,893262,857
Depreciation and impairment
At 01 February 2495,58712,273-134107,994
Charge for year14,39223,8418011,22940,263
At 31 January 25109,97936,1148011,363148,257
Net book value
At 31 January 2529,22071,5254,3259,530114,600
At 31 January 2443,61295,366-5,749144,727
4.Stocks

2025

2024

££
Raw materials and consumables2,5002,500
Total2,5002,500
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables11,0514,516
Other debtors399,085497,649
Prepayments and accrued income1,4521,263
Total411,588503,428
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables20,8831,705
Bank borrowings and overdrafts16,66716,667
Taxation and social security25,65512,835
Finance lease and HP contracts32,57032,569
Other creditors50,6058,572
Accrued liabilities and deferred income6,02332,161
Total152,403104,509
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts5,17121,898
Other creditors48,32380,892
Total53,494102,790
Included within creditors falling due within one year and creditors falling due after more than one year is £21,838 (2024: 38,565) in respect of a loan from Siemens. This loan is repayable by June 2026
8.Obligations under finance leases

2025

2024

££
Finance lease and HP contracts48,32280,892
9.Capital commitments
LEASING AGREEMENTS: Minimum lease payments under non-cancellable hire purchase lease in respect of motor vehicle and equipment fall due as follows: Due within one year: £32,569 (2024: £32,569) Between one and five years: £48,323 (2024:£80,892)
10.Other commitments
LEASING AGREEMENTS: Minimum lease payments under non-cancellable operating leases fall due as follows: Due within one year: £25,200 (2024: 25,200)
11.Related party transactions
Included in other creditors falling due within one year is an amount due to the director £25,128 (2024: Nil).